Wassil Jim's most recent trade in Vaxcyte Inc was a trade of 72,536 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 72,536 | 72,536 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 21,726 | 153,421 | - | 0 | Common Stock | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.07 per share. | 27 Feb 2025 | 5,915 | 157,016 | - | 73.1 | 432,215 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 73.02 per share. | 27 Feb 2025 | 5,649 | 159,070 | - | 73.0 | 412,490 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 5,362 | 71,664 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 27 Feb 2025 | 5,362 | 162,931 | - | 5.4 | 28,687 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.10 per share. | 27 Feb 2025 | 3,015 | 151,916 | - | 72.1 | 217,382 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.02 per share. | 27 Feb 2025 | 2,869 | 156,201 | - | 73.0 | 209,494 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 2,638 | 0 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 27 Feb 2025 | 2,638 | 157,569 | - | 2.4 | 6,384 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.84 per share. | 27 Feb 2025 | 2,085 | 154,931 | - | 73.8 | 153,950 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.02 per share. | 27 Feb 2025 | 1,270 | 154,931 | - | 73.0 | 92,735 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 8,000 | 2,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 03 Feb 2025 | 8,000 | 213,695 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 86.00 per share. | 03 Feb 2025 | 5,314 | 208,381 | - | 86.0 | 456,983 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 86.67 per share. | 03 Feb 2025 | 2,666 | 205,715 | - | 86.7 | 231,049 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 87.95 per share. | 03 Feb 2025 | 20 | 205,695 | - | 88.0 | 1,759 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 02 Jan 2025 | 8,000 | 213,695 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2025 | 8,000 | 10,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 83.69 per share. | 02 Jan 2025 | 5,483 | 206,856 | - | 83.7 | 458,861 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 82.88 per share. | 02 Jan 2025 | 1,356 | 212,339 | - | 82.9 | 112,381 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 84.43 per share. | 02 Jan 2025 | 1,161 | 205,695 | - | 84.4 | 98,024 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 74,000 | 131,695 | - | 0 | Common Stock | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 8,000 | 18,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 02 Dec 2024 | 8,000 | 213,695 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 92.07 per share. | 02 Dec 2024 | 5,772 | 207,923 | - | 92.1 | 531,416 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 94.06 per share. | 02 Dec 2024 | 1,127 | 205,695 | - | 94.1 | 106,008 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 93.06 per share. | 02 Dec 2024 | 1,101 | 206,822 | - | 93.1 | 102,460 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 87,481 | 87,481 | - | - | Performance Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 35,661 | 35,661 | - | - | Performance Restricted Stock Units | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 01 Nov 2024 | 8,000 | 213,695 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 8,000 | 26,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 106.34 per share. | 01 Nov 2024 | 4,955 | 208,740 | - | 106.3 | 526,920 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 107.20 per share. | 01 Nov 2024 | 2,174 | 206,566 | - | 107.2 | 233,057 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 108.25 per share. | 01 Nov 2024 | 631 | 205,935 | - | 108.2 | 68,303 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 108.93 per share. | 01 Nov 2024 | 240 | 205,695 | - | 108.9 | 26,143 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 3,464 | 89,876 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.93 per share. | 28 Oct 2024 | 3,464 | 205,695 | - | 20.9 | 72,502 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 28 Oct 2024 | 1,585 | 202,231 | - | 5.4 | 8,480 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 1,585 | 77,026 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 8,000 | 34,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 01 Oct 2024 | 8,000 | 208,646 | - | 2.4 | 19,360 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 114.32 per share. | 01 Oct 2024 | 3,349 | 202,985 | - | 114.3 | 382,841 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 114.95 per share. | 01 Oct 2024 | 2,339 | 200,646 | - | 114.9 | 268,861 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 113.41 per share. | 01 Oct 2024 | 2,312 | 206,334 | - | 113.4 | 262,215 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 10,000 | 42,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 16 Sep 2024 | 10,000 | 211,958 | - | 2.4 | 24,200 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 116.14 per share. | 16 Sep 2024 | 7,994 | 202,180 | - | 116.1 | 928,399 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 115.06 per share. | 16 Sep 2024 | 1,784 | 210,174 | - | 115.1 | 205,271 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 116.96 per share. | 16 Sep 2024 | 222 | 200,646 | - | 117.0 | 25,965 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 03 Sep 2024 | 10,000 | 217,503 | - | 2.4 | 24,200 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 10,000 | 52,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.15 per share. | 03 Sep 2024 | 5,545 | 201,958 | - | 110.2 | 610,782 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 111.02 per share. | 03 Sep 2024 | 3,102 | 212,071 | - | 111.0 | 344,388 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 111.85 per share. | 03 Sep 2024 | 2,263 | 209,808 | - | 111.8 | 253,107 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 110.08 per share. | 03 Sep 2024 | 2,072 | 215,173 | - | 110.1 | 228,085 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 116.43 per share. | 03 Sep 2024 | 1,195 | 207,513 | - | 116.4 | 139,128 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 114.25 per share. | 03 Sep 2024 | 389 | 209,052 | - | 114.3 | 44,445 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 112.95 per share. | 03 Sep 2024 | 367 | 209,441 | - | 112.9 | 41,452 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 115.15 per share. | 03 Sep 2024 | 344 | 208,708 | - | 115.1 | 39,610 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 108.01 per share. | 03 Sep 2024 | 258 | 217,245 | - | 108.0 | 27,867 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 117.00 per share. | 03 Sep 2024 | 10 | 207,503 | - | 117 | 1,170 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 78.84 per share. | 01 Aug 2024 | 2,977 | 207,526 | - | 78.8 | 234,699 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 79.48 per share. | 01 Aug 2024 | 23 | 207,503 | - | 79.5 | 1,828 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 76.71 per share. | 01 Jul 2024 | 1,663 | 210,614 | - | 76.7 | 127,566 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 75.75 per share. | 01 Jul 2024 | 1,226 | 212,277 | - | 75.8 | 92,875 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 77.22 per share. | 01 Jul 2024 | 111 | 210,503 | - | 77.2 | 8,571 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 71.38 per share. | 03 Jun 2024 | 1,634 | 214,869 | - | 71.4 | 116,641 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 72.32 per share. | 03 Jun 2024 | 906 | 213,964 | - | 72.3 | 65,521 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.48 per share. | 03 Jun 2024 | 460 | 213,503 | - | 73.5 | 33,799 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 61.23 per share. | 01 May 2024 | 1,753 | 216,709 | - | 61.2 | 107,331 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 61.99 per share. | 01 May 2024 | 1,062 | 215,647 | - | 62.0 | 65,837 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 63.65 per share. | 01 May 2024 | 185 | 215,462 | - | 63.6 | 11,775 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 17 Apr 2024 | 3,551 | 221,840 | - | 5.4 | 18,998 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 3,551 | 78,611 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 66.53 per share. | 01 Apr 2024 | 2,323 | 218,966 | - | 66.5 | 154,552 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 67.23 per share. | 01 Apr 2024 | 677 | 218,289 | - | 67.2 | 45,514 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 4,099 | 222,773 | - | 0 | Common Stock | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.70 per share. | 15 Mar 2024 | 1,484 | 221,289 | - | 69.7 | 103,435 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 20,000 | 223,852 | - | 0 | Common Stock | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.55 per share. | 29 Feb 2024 | 2,178 | 218,674 | - | 71.6 | 155,836 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.62 per share. | 29 Feb 2024 | 1,220 | 221,615 | - | 73.6 | 89,821 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.08 per share. | 29 Feb 2024 | 1,017 | 222,835 | - | 73.1 | 74,320 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 74.69 per share. | 29 Feb 2024 | 763 | 220,852 | - | 74.7 | 56,992 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 15 Feb 2024 | 27,917 | 203,852 | - | 2.4 | 67,559 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 27,917 | 62,638 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,000 | 90,555 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Wassil Jim | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 01 Feb 2024 | 3,000 | 178,935 | - | 2.4 | 7,260 | Common Stock |
| Vaxcyte Inc | Wassil Jim | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 73.34 per share. | 01 Feb 2024 | 1,056 | 177,352 | - | 73.3 | 77,452 | Common Stock |
| Vaxcyte Inc | Wassil Jim | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 75.28 per share. | 01 Feb 2024 | 950 | 175,935 | - | 75.3 | 71,515 | Common Stock |
| Vaxcyte Inc | Jim Wassil | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 72.18 per share. | 01 Feb 2024 | 527 | 178,408 | - | 72.2 | 38,037 | Common Stock |
| Vaxcyte Inc | Wassil Jim | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 74.14 per share. | 01 Feb 2024 | 467 | 176,885 | - | 74.1 | 34,622 | Common Stock |
| Vaxcyte Inc | Jim Wassil | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 3,000 | 93,555 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Wassil Jim | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 02 Jan 2024 | 3,000 | 178,935 | - | 2.4 | 7,260 | Common Stock |
| Vaxcyte Inc | Jim Wassil | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 64.29 per share. | 02 Jan 2024 | 1,562 | 176,045 | - | 64.3 | 100,426 | Common Stock |
| Vaxcyte Inc | Jim Wassil | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 63.55 per share. | 02 Jan 2024 | 1,039 | 177,607 | - | 63.5 | 66,025 | Common Stock |
| Vaxcyte Inc | Jim Wassil | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 62.71 per share. | 02 Jan 2024 | 289 | 178,646 | - | 62.7 | 18,123 | Common Stock |
| Vaxcyte Inc | Wassil Jim | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 65.15 per share. | 02 Jan 2024 | 110 | 175,935 | - | 65.2 | 7,167 | Common Stock |
| Vaxcyte Inc | Jim Wassil | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 3,000 | 96,555 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Wassil Jim | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 01 Dec 2023 | 3,000 | 178,935 | - | 2.4 | 7,260 | Common Stock |